N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide

C31H39N5O5 — CID 46002720

IUPACN-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide
SMILESCCC(C)CN(CC(=O)N1CCN(c2ccc(-c3ccc(OC)cc3OC)nn2)CC1)C(=O)c1cccc(OC)c1
InChIInChI=1S/C31H39N5O5/c1-6-22(2)20-36(31(38)23-8-7-9-24(18-23)39-3)21-30(37)35-16-14-34(15-17-35)29-13-12-27(32-33-29)26-11-10-25(40-4)19-28(26)41-5/h7-13,18-19,22H,6,14-17,20-21H2,1-5H3
InChIKeyIXNBBVCDVNEOSQ-UHFFFAOYSA-N
MW561.68 g/mol
LogP4.01
Rot. Bonds11

About N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide

N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide (PubChem CID 46002720) has the molecular formula C31H39N5O5 and a molecular weight of 561.68 g/mol. Its IUPAC name is N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide.

Molecular Properties

Compound NameN-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide
PubChem CID46002720
Molecular FormulaC31H39N5O5
Molecular Weight561.68 g/mol
Exact Mass561.30
IUPAC NameN-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide
SMILESCCC(C)CN(CC(=O)N1CCN(c2ccc(-c3ccc(OC)cc3OC)nn2)CC1)C(=O)c1cccc(OC)c1
InChIInChI=1S/C31H39N5O5/c1-6-22(2)20-36(31(38)23-8-7-9-24(18-23)39-3)21-30(37)35-16-14-34(15-17-35)29-13-12-27(32-33-29)26-11-10-25(40-4)19-28(26)41-5/h7-13,18-19,22H,6,14-17,20-21H2,1-5H3
InChIKeyIXNBBVCDVNEOSQ-UHFFFAOYSA-N
XLogP4.01
TPSA97.33 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds11
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500561.68
LogP ≤ 54.01
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide?
The IUPAC name of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide (CID 46002720) is N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide.
What is the SMILES notation for N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide?
The canonical SMILES for N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide is CCC(C)CN(CC(=O)N1CCN(c2ccc(-c3ccc(OC)cc3OC)nn2)CC1)C(=O)c1cccc(OC)c1.
What is the InChIKey of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide?
The InChIKey is IXNBBVCDVNEOSQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H39N5O5/c1-6-22(2)20-36(31(38)23-8-7-9-24(18-23)39-3)21-30(37)35-16-14-34(15-17-35)29-13-12-27(32-33-29)26-11-10-25(40-4)19-28(26)41-5/h7-13,18-19,22H,6,14-17,20-21H2,1-5H3.
What are the key properties of N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide?
N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide has a molecular weight of 561.68 g/mol, XLogP of 4.01, 11 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[6-(2,4-dimethoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-3-methoxy-N-(2-methylbutyl)benzamide is sourced from PubChem (CID 46002720), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).